NovoCure Ltd

NovoCure Ltd

NVCR

Market Cap$1.89B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NovoCure LtdNovoCure Ltd-12.6--42%3.61.8
$27.00

Target Price by Analysts

48.4% upsideNovoCure Ltd Target Price DetailsTarget Price
$1.17

Current Fair Value

93.6% downside

Overvalued by 93.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.89 Billion
Enterprise Value$2.36 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.95
Beta0.71
Outstanding Shares108,247,716

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-12.6
PEG32.97
Price to Sales3.64
Price to Book Ratio6.06
Enterprise Value to Revenue4.08
Enterprise Value to EBIT-20.58
Enterprise Value to Net Income-16
Total Debt to Enterprise0.28
Debt to Equity1.81

Revenue Sources

No data

Insider Trades

ESG Score

No data

About NovoCure Ltd

CEO: Asaf Danziger